XML 22 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows provided by (used in) operating activities:    
Net income (loss) $ 161,233 $ 213,849
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Total realized investment (gains) losses 83,355 (37,286)
Net realized and unrealized (gains) losses on derivative instruments (4,221) 7,069
Amortization of premiums (discounts) on fixed maturities 32,298 42,178
(Income) loss from investment and operating affiliates (39,800) (28,921)
Share-based compensation 15,448 12,694
Depreciation and amortization 22,481 19,429
Accretion of deposit liabilities 11,125 11,430
Changes in:    
Unpaid losses and loss expenses (240,207) 290,788
Future policy benefit reserves (51,981) (55,634)
Funds withheld on GreyCastle life retrocession arrangements, net (24,578) (107,596)
Unearned premiums 1,310,888 1,222,570
Premiums receivable (979,464) (1,152,760)
Unpaid losses and loss expenses recoverable 36,804 (153,063)
Ceded unearned premiums (730,516) (797,191)
Reinsurance balances receivable (272,531) (59,052)
Deferred acquisition costs and value of business acquired (205,798) (205,830)
Reinsurance balances payable 695,220 849,492
Deferred tax asset - net 25,190 10,852
Derivatives 8,162 58,104
Other assets (42,006) (100,791)
Other liabilities (51,327) (128,606)
Other 25,022 (9,323)
Total adjustments (399,357) (261,346)
Net cash provided by (used in) operating activities (238,124) (47,497)
Cash flows provided by (used in) investing activities:    
Proceeds from sale of fixed maturities and short-term investments 4,369,199 2,492,005
Proceeds from redemption of fixed maturities and short-term investments 701,404 1,228,356
Proceeds from sale of equity securities 78,716 46,379
Purchases of fixed maturities and short term investments (4,917,191) (3,633,007)
Purchases of equity securities (33,230) (47,967)
Proceeds from sale of affiliates 244,340 168,237
Purchases of affiliates (76,014) (35,926)
Other, net (26,782) 23,429
Net cash provided by (used in) investing activities 340,442 241,506
Cash flows provided by (used in) financing activities:    
Proceeds from issuance of ordinary shares and exercise of stock options 46,504 23,296
Buybacks of common shares (1,663) (200,488)
Employee withholding on share-based compensation (16,696) (22,871)
Dividends paid on common shares 0 (58,392)
Distributions to non-controlling interests (15,946) (25,400)
Contributions from non-controlling interests 439 26
Contingent consideration paid on business combination (5,000) 0
Deposit liabilities (71,124) (7,771)
Net cash provided by (used in) financing activities (63,486) (291,600)
Effects of exchange rate changes on foreign currency cash 7,503 30,273
Increase (decrease) in cash, cash equivalents and restricted cash 46,335 (67,318)
Cash, cash equivalents and restricted cash - beginning of year 3,593,451 3,580,492
Cash, cash equivalents and restricted cash - end of period 3,639,786 3,513,174
Life Funds Withheld Assets    
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Net realized and unrealized (gains) losses on derivative instruments $ (22,921) $ 50,101